Related Experiment Video
Updated: May 2, 2026

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
Published on: June 8, 2016
Endoscopically Deliverable Polymer Adhesives with pH-Triggered Multiple Molecular Evolution for Gastric Ulcer Repair
Jiaying Liu1,2, Qingyun Chu1, Renjie Li1
1School of Chemistry, Xi'an Key Laboratory of Sustainable Polymer Materials, State Key Laboratory of Fluorine & Nitrogen Chemicals, Engineering Research Center of Energy Storage Materials and Devices Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, P. R. China.
None:
Hydrogel adhesives show promise for gastric ulcer treatment, while facing challenges in endoscopic delivery, wet adhesion, and long-term gastric retention. Here, we engineered a sequential pH-responsive adhesive (PNMH) by polymerizing β-carboxylic-amide-functionalized N-acryloyl phenylalanine and hydroxyethyl acrylamide. Acid-induced protonation followed by hydrolysis of the β-carboxylic amide drives a pH-triggered quadruple evolution of intermolecular interactions from electrostatic repulsion to hydrophobicity-assisted hydrogen bonding, then to hydrophobicity-assisted electrostatic interaction, and finally to cation-π interaction. This unique mechanism enables facile endoscopic administration of PNMH and ultrafast gelation within ∼4 s upon exposure to gastric acid, forming a robust network and simultaneously displacing interfacial water to achieve immediate tissue adhesion (∼24.1 kPa). Furthermore, the interfacial adhesion strength with wet gastric tissue progressively intensifies to 34.3 kPa in the early stage of hydrolysis while maintaining long-term interfacial integration over 30 days under simulated gastric conditions. Moreover, PNMH exhibits a prolonged in vivo residence time of more than 4 days through in situ injection into the rat stomach. Rat and pig experiments demonstrate that PNMH, as a durable shield, protects ulcers from gastric acid/pepsin erosion and orchestrates healing through attenuating immune activation, suppressing matrix metalloproteinase-9 overexpression and promoting cytoskeleton-driven restoration of the mucosal barrier. Our work presents an advanced molecular design strategy for gastric-resistant polymer adhesives and provides a promising candidate for clinical gastric ulcer treatment.
More Related Videos
06:34Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
06:25Fabrication of Dissolvable Microneedle Patches Loaded with α-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction
Published on: December 30, 2025
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Oral Drug Delivery Systems: Delayed-Release Systems
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention